Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 32 (3), 237-244
- https://doi.org/10.1016/j.jpainsymman.2006.03.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vitamin E for prophylaxis against chemotherapy-induced neuropathyNeurology, 2005
- α‐tocopherol protects against cisplatin‐induced toxicity without interfering with antitumor efficacyInternational Journal of Cancer, 2003
- Managing the Neurotoxicity of Paclitaxel (Taxol®) and Docetaxel (Taxotere®) with Neurotrophic FactorsCancer Investigation, 2000
- Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patientsAnnals of Oncology, 1998
- Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapyEuropean Journal Of Cancer, 1997
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994
- Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.Journal of Clinical Oncology, 1992
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Reporting results of cancer treatmentCancer, 1981